Google taps AI to revamp costly healthcare push marred by flops
Alphabet Inc. has been working furiously to bring generative AI to the public, but the technology could also help the company make inroads in healthcare.
Related Articles
Innovating Video Streaming: Edge Nodes, AI-Driven Caching, and Sustainable CDN Solutions
Interested in being a guest? Email us at admin@evankirstel.comDiscover how video streaming is being transformed in the most challenging environments with Steve
Volunteers work to reopen land that inspired poet John Clare
The John Clare Countryside Project will see habitats return to the 19th Century poet’s beloved home.
Unveiling MedTech Innovations: FPT’s AI Ventures, Cardinal Peak Integration, and Future Clinical Tech Insights
Interested in being a guest? Email us at admin@evankirstel.comReady to uncover the future of AI in MedTech? Join us as we promise a deep dive…
Bradford: Takeaway project aims to cut obesity levels
The scheme hopes to give people healthier choices from fast food restaurants.
Weight loss drug liraglutide is safe and effective in children under 12, study finds
The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the…
Hopes for new hip replacement surgery tool from University of Cambridge
Surgeons “balance” the joint based on “feel” and the new technology may change that.
After FDA rejection, Sanofi and Regeneron’s Dupixent succeeds in late-stage trial of chronic hives
Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with an inflammatory skin disease in a late-stage trial.
Tranmere Rovers plans to be England’s first ‘suicide-safer’ club
The club said it wanted to get the message across to people that “there is always hope”.
Buckinghamshire SEND child left without transport for new term
The council says it provides school transport for 7,500 students who are eligible.
Multiple sclerosis: University student joins pioneering study
Kent student Jiangwei Liao is the first patient to join an international treatment trial for MS.